Index
S&P 500
Market Cap
11.01B
Enterprise Value
13.87B
Income
57.43M
Sales
5.91B
Book/sh
68.14
Cash/sh
13.83
Employees
7800
IPO
Feb 22, 1994
P/E
-
Forward P/E
9.58
PEG
-
P/S
1.86
P/B
1.37
P/C
6.75
P/FCF
8.20
EV/EBITDA
9.37
EV/Sales
2.35
Quick Ratio
1.35
Current Ratio
2.09
Debt/Eq
0.19
LT Debt/Eq
0.18
Option/Short
Yes / Yes
EPS (ttm)
-0.04
EPS next Y
9.74
EPS next Q
2.53
EPS this Y
1507.61%
EPS next Y
-12.45%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-11.10% 10.45%
EPS Y/Y TTM
105.11%
Sales Y/Y TTM
18.32%
EPS Q/Q
2114.78%
Sales Q/Q
31.08%
Insider Own
0.26%
Insider Trans
-5.07%
Inst Own
100.67%
Inst Trans
5.19%
ROA
1.35%
ROE
2.19%
ROIC
1.84%
Gross Margin
23.84%
Oper. Margin
14.12%
Profit Margin
0.97%
SMA20
-4.97%
SMA50
-17.25%
SMA200
-37.99%
Trades
Shs Outstand
117.99M
Shs Float
117.69M
52W High
221.00 -57.80%
52W Low
88.01 5.98%
Volatility
2.82% 3.02%
ATR (14)
3.74
RSI (14)
34.76
Beta
1.32
Rel Volume
1.03
Avg Volume
2.38M
Volume
2,460,213
Perf Week
0.79%
Perf Month
-11.83%
Perf Quarter
-20.72%
Perf Half Y
-52.58%
Perf YTD
-34.06%
Perf Year
-4.63%
Perf 3Y
-30.62%
Perf 5Y
-62.76%
Perf 10Y
12.50%
Prev Close
96.96
Price
93.27
Change %
-3.81%
Analysts 14 incl. previous ratings
Rating Distribution 9 Buy · 5 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 14, 2026 Upgrade M Mizuho
Neutral → Outperform Oct 13, 2026 Initiated B Barclays
Equal Weight $109 +16.9% Jun 18, 2026 Upgrade C Citigroup
Neutral → Buy $225 +141.2% May 26, 2026 Upgrade V Vertical Research
Hold → Buy $224 +140.2% Apr 22, 2026 Downgrade R Rothschild & Co Redburn
Buy → Neutral $188 +101.6% Apr 17, 2026 Downgrade R Robert W. Baird
Outperform → Neutral $210 +125.2% Feb 17, 2026 Upgrade B BofA Securities
Neutral → Buy $190 +103.7% Jan 21, 2026 Upgrade T Truist
Hold → Buy $205 +119.8% Jan 20, 2026 Upgrade H HSBC Securities
Hold → Buy $200 +114.4% Jan 13, 2026 Upgrade D Deutsche Bank
Hold → Buy $185 +98.3% Jan 12, 2026 Upgrade B Scotiabank
Sector Perform → Sector Outperform $200 +114.4% Jan 07, 2026 Upgrade R Robert W. Baird
Neutral → Outperform $210 +125.2% Dec 16, 2025 Upgrade M Morgan Stanley
Underweight → Equal-Weight $147 +57.6% Dec 05, 2025 Upgrade U UBS
Neutral → Buy $185 +98.3% Dec 02, 2025 Upgrade R Robert W. Baird
Underperform → Neutral $113 +21.2% Oct 24, 2025 Initiated R Rothschild & Co Redburn
Buy $135 +44.7% Oct 20, 2025 Reiterated T Truist
Hold $72 → $87 -6.7% Oct 14, 2025 Downgrade B BofA Securities
Buy → Neutral $100 +7.2% Aug 26, 2025 Upgrade U UBS
Sell → Neutral $89 -4.6% Jul 30, 2025 Downgrade K KeyBanc Capital Markets
Overweight → Sector Weight
Show Previous Ratings
Oct-27-26 04:30PM
03:18PM
Oct-26-26 04:15PM
Oct-20-26 08:00PM
Oct-16-26 08:30AM
11:12AM
Loading…
Oct-14-26 11:12AM
09:27AM
08:53AM
Oct-13-26 03:00AM
Oct-11-26 10:48AM
Oct-06-26 10:00AM
Oct-01-26 04:15PM
Sep-17-26 04:30PM
Sep-11-26 07:06AM
Sep-03-26 08:00AM
04:30PM
Loading…
Aug-25-26 04:30PM
Aug-21-26 04:30PM
Aug-17-26 08:00PM
Aug-14-26 03:09PM
Aug-06-26 04:48PM
04:30PM
03:05PM
Aug-05-26 05:06PM
04:26PM
04:15PM
Jul-28-26 08:00PM
08:00AM
Jul-23-26 04:15PM
Jul-21-26 04:15PM
Jul-16-26 08:00PM
09:06AM
Loading…
09:06AM
Jul-07-26 04:15PM
08:00AM
Jun-30-26 11:34AM
Jun-25-26 03:00PM
Jun-18-26 08:58AM
Jun-11-26 04:30PM
(MarketWatch)
+8.04%
+7.14%
May-15-26 04:30PM
May-14-26 04:30PM
May-13-26 08:00PM
May-07-26 12:33PM
(Investor's Business Daily)
12:30PM
10:46AM
08:49AM
(Investor's Business Daily)
May-06-26 04:37PM
04:15PM
May-05-26 04:15PM
May-04-26 02:33PM
May-01-26 12:00PM
11:59AM
(Investor's Business Daily)
Apr-22-26 12:30PM
Apr-17-26 12:22PM
12:09PM
06:53AM
Apr-16-26 03:23PM
02:07PM
(Investor's Business Daily)
Apr-13-26 03:45AM
Apr-06-26 04:15PM
Mar-27-26 09:02AM
Mar-23-26 07:55PM
(Barrons.com)
+6.93%
+5.67%
Mar-16-26 04:15PM
06:50AM
Mar-13-26 10:50AM
Mar-11-26 10:03AM
03:18AM
Mar-10-26 09:57AM
09:40AM
09:00AM
Mar-09-26 08:42AM
Mar-07-26 11:08AM
08:21AM
Mar-05-26 05:50PM
Mar-04-26 12:10PM
09:19AM
09:16AM
09:05AM
07:27AM
07:15AM
07:04AM
Mar-03-26 05:10PM
(The Wall Street Journal)
-7.55%
02:28PM
04:37AM
Mar-02-26 04:40PM
04:25PM
04:15PM
12:44PM
08:55AM
07:51AM
Feb-27-26 12:00PM
09:09AM
09:00AM
07:54AM
07:47AM
Feb-26-26 04:15PM
03:00PM
12:20PM
08:54AM
Feb-25-26 04:32PM
12:59PM
(Investor's Business Daily)
10:18AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Masters J Kent Chairman & CEO May 15 '26 Sale 183.72 16,393 3,011,766 87,519 May 19 04:37 PM Jerry Kent Masters Jr. Officer May 15 '26 Proposed Sale 180.38 16,393 2,956,969 May 15 04:49 PM Masters J Kent Chairman & CEO Mar 10 '26 Sale 170.81 11,783 2,012,688 134,628 Mar 12 06:49 PM Jerry Kent Masters Jr. Officer Mar 10 '26 Proposed Sale 166.54 11,783 1,962,341 Mar 10 04:14 PM Norris Eric Chief Commercial Officer Feb 20 '26 Sale 165.45 5,692 941,741 48,819 Feb 23 04:33 PM STEINER GERALD A Director Feb 18 '26 Option Exercise 0.00 934 0 11,946 Feb 20 04:15 PM Eric W Norris Officer Feb 19 '26 Proposed Sale 174.50 5,692 993,254 Feb 20 02:03 PM Anderson Melissa H. Chief Bus..Transformation Off. Feb 13 '26 Sale 163.71 8,454 1,384,004 9,439 Feb 18 04:21 PM Sheorey Neal Ravi Chief Financial Officer Nov 06 '25 Option Exercise 0.00 1,953 0 13,064 Nov 10 04:13 PM Netha Johnson Former Employee Nov 07 '25 Proposed Sale 96.89 38,531 3,733,080 Nov 07 04:09 PM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.
Chairman Mr. Jerry Kent Masters Jr.
CFO & Executive VP Mr. Neal R. Sheorey
Executive VP & COO Mr. Mark R. Mummert
Executive VP & Chief Commercial Officer Mr. Eric W. Norris
Executive VP & Chief Business Transformation Officer Ms. Melissa H. Anderson